<DOC>
	<DOCNO>NCT00798629</DOCNO>
	<brief_summary>RATIONALE : Vaccines make gene-modified tumor cell may help body build immune response kill tumor cell . PURPOSE : This phase I trial study side effect best dose vaccine therapy treat patient metastatic melanoma .</brief_summary>
	<brief_title>Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured</brief_title>
	<detailed_description>In phase I study , patient receive intradermal injection adenovirus-CCL-21 transduced class I peptide-pulsed DC total volume intradermal injection 1 ml split four injection 0.25 ml four limb node drain area ( proximal arm thigh ) , total DC dose 2 X 10^6 , 10^7 2 X 10^7 cell administer intradermally . DC injections one course therapy give four time interval weekly two dos ( day 1 8 +/- 72 hr . ) , every two week two dos ( day 22 +/- 72 hr . 36 +/- 72 hour ) . Cells harvest DC administration flow cytometry analysis well microbiologic analysis include bacterial/fungal culture gram stain perform prior infusion . All injection base number DC , number total cell .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Metastatic melanoma measurable disease attempt curative surgical therapy receive least one prior chemotherapy regimen ; adjuvant interferon isolate limb perfusion allow . Tumor tissue must available immunohistochemical analysis , specimen stain MART1 immunohistochemical staining also stain HMB45 immunohistochemistry , positivity least one entry requirement . Patients must HLAA *0201 positive , DNA SSOP analysis . Serum creatinine 2.0 mg/dl less , total bilirubin 2.0 mg/dl less , ALT/AST le 3X institutional upper limit normal . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Patients must able understand sign IRB approve informed consent form . Patients must white blood count 3000 great , platelet 100,000 great , hemoglobin 9.0 gm/dl . Patients unresectable stage III/IV uveal melanoma metastatic mucosal melanoma eligible trial . Undergoing undergone past month therapy melanoma , include radiation therapy , chemotherapy adjuvant therapy Have major systemic infection , coagulation disorder , major medical illness cardiovascular respiratory system , document MI last 6 month Require steroid therapy Patients pregnant lactate Known positive hepatitis BsAg , Hepatitis C HIV antibody Have prior history uveitis autoimmune inflammatory eye disease Have another malignancy cervical carcinomainsitu basal cell /squamous cancer skin , unless undergone curative therapy 3 year ago still free detectable disease , since effect peptidepulsed DC active cancer unknown</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>mucosal melanoma</keyword>
</DOC>